trial

Precision HD-tACS for Enhancing Sensory Experience in Schizophrenia

NCTId NCT07632261
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 80 (estimated)
Sponsored by Hôpital le Vinatier
Primary completion 2026-06-15
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
80 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2026-06-15
Primary completion
2026-06-15
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Transcranial neurostimulation

Sponsors

Hôpital le VinatierLead Sponsor

Investigators

1
William VALLET, PhDPrincipal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
80
Phase
NA
Primary Completion Date
2026-06-15
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
Transcranial neurostimulation
drug
lead_sponsor
Hôpital le Vinatier
company
indication
SCHIZOPHRENIA 1 (Disorder)
indication
Sensory Perceptual Characteristics
indication
investigator
William VALLET, PhD
person